References
Clark CWF, El Mahdi EO (1985) Confusion and paranoia associated with tocainide. Postgrad Med J 61:79–81
Horn HR, Hadidian Z, Johnson JL, Vassallo JG, Williams JH, Young D (1980) Safety evaluation of tocainide in American Emergency Use Programme. Am Heart J 100:1037
Mielke U, Haass A, Sen S, Schmidt W (1985) Antimyotonic therapy with tocainide under ECG control in the myotonic dystrophy of Curschmann-Steinert. J Neurol 232:271–274
Ryan W, Engler R, Le Winter M, Kaliner JS (1979) Efficacy of a new oral agent (tocainide) on the acute treatment of refractory ventricular arrhythmias. Am J Cardiol 43:285
Volosin K, Greenberg RM, Greenspon AJ (1985) Tocainide induced agranulocytosis. Am Heart J 109:1392–1393
Horn HR, Hadidian Z, Johnson JL, Vassallo HG, Williams JH, Young MD (1980) Safety evaluation of tocainide in the American Emergency Use Program. Am Heart J 100:1037–1040
Ricker R, Haass A, Rüdel R, Bohlen R, Mertens HG (1980) Successful treatment of paramyotonia congenita (Eulenburg): muscle stiffness and weakness prevented by tocainide. J Neurol Neurosurg Psychiatry 43:268–271
Volosin K, Greenberg RM, Greenspon AJ (1985) Tocainide associated agranulocytosis. Am Heart J 109:1392–1393
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Harries-Jones, R., Mielke, U. Tocainide and myotonic dystrophy. J Neurol 233, 192 (1986). https://doi.org/10.1007/BF00314435
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00314435